Paulina Linares

Statistics

Publications

Citations

708

H-Index

Active since

2018

Affiliations

University of California, Los Angeles(Current)

Paulina Linares is an author at University of California, Los Angeles specializing in oncology, pharmacotherapy, and tyrosine kinase inhibitor therapy.

Publications per year

2018–2018

Publications

A Phase II Study of Pembrolizumab in EGFR-Mutant, PD-L1+, Tyrosine Kinase Inhibitor Naïve Patients With Advanced NSCLC

Aaron Lisberg, Amy L. Cummings, Jonathan W. Goldman et al. · Journal of Thoracic Oncology · 2018 · 592 citations · Full text

Medicine, Oncology, Pharmacology +15

Treatment-Related Adverse Events Predict Improved Clinical Outcome in NSCLC Patients on KEYNOTE-001 at a Single Center

Aaron Lisberg, D. Andrew Tucker, Jonathan W. Goldman et al. · Cancer Immunology Research · 2018 · 104 citations

Medicine, Oncology, Pharmacotherapy +16

A randomized phase 2 study of nivolumab monotherapy versus nivolumab combined with ipilimumab in patients with metastatic or unresectable gastrointestinal stromal tumor (GIST).

Arun S. Singh, Bartosz Chmielowski, J. Randolph Hecht et al. · Journal of Clinical Oncology · 2018 · 12 citations

Pharmacy, Oncology, Pharmacotherapy +17

1–3 of 3